Adjuvant chemotherapy in elderly patients with primary breast cancer: are women ≥65 undertreated?

Adjuvant chemotherapy in elderly patients with primary breast cancer: are women ≥65 undertreated?

Purpose To establish whether women over 65 years of age with newly diagnosed with breast cancer (BC) receive adjuvant chemotherapy less frequently than younger postmenopausal women and whether comorbidity influences this potential undertreatment. Materials and methods In a single-site, retrospective...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cancer research and clinical oncology 2016-08, Vol.142 (8), p.1847-1853
Hauptverfasser: Wallwiener, C. W., Hartkopf, A. D., Grabe, E., Wallwiener, M., Taran, F.-A., Fehm, T., Brucker, S. Y., Krämer, B.
Format: Artikel
Sprache:eng
Schlagworte:
Aged
Aged, 80 and over
Breast cancer
Breast Neoplasms - drug therapy
Cancer Research
Chemotherapy
Chemotherapy, Adjuvant - utilization
Comorbidity
Female
Hematology
Humans
Internal Medicine
Medicine
Medicine & Public Health
Older people
Oncology
Original Article – Clinical Oncology
Retrospective Studies
Survival Analysis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose To establish whether women over 65 years of age with newly diagnosed with breast cancer (BC) receive adjuvant chemotherapy less frequently than younger postmenopausal women and whether comorbidity influences this potential undertreatment. Materials and methods In a single-site, retrospective, comparative study, postmenopausal early stage BC patients treated between 01/2001 and 12/2005 at a major German university hospital were analyzed in two age Groups A and B (≥65 vs.
ISSN:0171-5216
1432-1335
DOI:10.1007/s00432-016-2194-4